Patents for C12P 21 - Preparation of peptides or proteins (112,499)
02/2007
02/08/2007WO2007014456A1 Cancerous disease modifying antibodies
02/08/2007WO2007014455A1 Cancerous disease modifying antibodies
02/08/2007WO2006121852A3 Anti-cd19 antibody therapy for autoimmune disease
02/08/2007WO2006065975A8 Methods of treating ankylosing spondylitis using anti-tnf antibodies and peptides of human tumor necrosis factor
02/08/2007WO2006042109A3 An apparatus for and method of sampling and collecting powders flowing in a gas stream
02/08/2007WO2005052117A3 Improved methods of in vitro protein synthesis
02/08/2007WO2005044987A3 Tocopherol associated protein and uses thereof
02/08/2007WO2004044124A3 Identification of oligoadenylate synthetase-like genes
02/08/2007WO2003068934A3 Chimeric molecules for cleavage in a treated host
02/08/2007US20070033669 Semaphorin gene family
02/08/2007US20070032643 Cis-element regulating transcription, transcriptional regulatory factor binding specifically thereto and use of the same
02/08/2007US20070032642 Novel genes and their use in the modulation of obesity, diabetes and energy imbalance
02/08/2007US20070032419 Fusion polypeptide, which comprise a peptide of 3-30 amino acids, which permits the fusion polypeptide to be bound selectively to tumor vessel endothelial cells, and the tissue factor or a fragment thereof; enables the fusion polypeptide to be bound selectively to tumor vessel endothelial cells
02/08/2007US20070032415 Compositions, splice variants and methods relating to breast specific genes and proteins
02/08/2007US20070031979 Protein biopolymer markers predictive of type II diabetes
02/08/2007US20070031969 Bacteria with reduced genome
02/08/2007US20070031965 Chimeric molecules that contain at least one pathogen-detection domain and at least one effector domain; use in preventing or treating a pathogen infection in a cell or organism
02/08/2007US20070031945 High mannose proteins and methods of making high mannose proteins
02/08/2007US20070031940 Methods for inducing differentiation of undifferentiated mammalian cells into osteoblasts
02/08/2007US20070031938 Organic anion transporting (oat)-like protein ust3-like1 and uses thereof
02/08/2007US20070031936 Nucleic acid sequences having gene transcription regulatory qualities
02/08/2007US20070031935 Nucleic acid sequences having gene transcription regulatory qualities
02/08/2007US20070031934 Nucleic acid sequences having gene transcription regulatory qualities
02/08/2007US20070031933 Determining whether a DNA sequence comprises a gene transcription modulating quality and/or a gene transcription repressing quality; systematic elucidation and identification of regulatory sequences
02/08/2007US20070031932 Cultures of E1-immortalized cells and processes for culturing the same to increase product yields therefrom
02/08/2007US20070031931 Biosynthetic binding proteins for immuno-targeting
02/08/2007US20070031930 Includes lowering the pH of a whole E coli cell solution to form an acidic solution, disrupting the cells to release the protein into the acidic solution, and separating the cellular debris from the released protein to obtain a protein product enriched in the heterologous target protein
02/08/2007US20070031929 Polypeptides Homologous To VEGF and BMP1
02/08/2007US20070031928 Glucoamylase variants
02/08/2007US20070031927 Biological system and assay for identifying inhibitors of tubulin glutamylases
02/08/2007US20070031926 Refolded membrane protein in monodisperse form
02/08/2007US20070031925 Small molecular weight TNF receptor multimeric molecule
02/08/2007US20070031924 recombinant polynucleotide that encodes a cell surface polypeptide comprising a biomolecule partition motif that can direct targeting of intracellular polypeptides to and through membranes, including cell surface membranes
02/08/2007US20070031923 Modified viral particles with immunogenic properties and reduced lipid content useful for treating and preventing infectious diseases
02/08/2007US20070031922 Nucleotide sequences coding chimeric immunoglobulin comprising salavage receptor binding epitope for use as reporter in immunodiagnostic and immunotherapeutics
02/08/2007US20070031921 Potent combinations of mrna transport elements
02/08/2007US20070031920 High expression locus vector based on ferritin heavy chain gene locus
02/08/2007US20070031904 Mammalian IAP gene family, primers, probes and detection methods
02/08/2007US20070031903 Mammalian IAP gene family, primers, probes and detection methods
02/08/2007US20070031899 Using serine/threonine kinase Pim-1 polypeptide phosphorylation inhibition after exposure to modulator as indication of antitumor/cancer activity; treating pancreatic cancer
02/08/2007US20070031896 Anti-CCR4 antibodies and methods of use therefor
02/08/2007US20070031894 Novel nerve stem cell marker
02/08/2007US20070031888 Human leucine-rich repeat containing protein expressed predominately in small intestine, HLRRSI1
02/08/2007US20070031882 Methods and compositions for treating AIDS and HIV-related disorders using 1414, 1481,1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784 or 2045 molecules
02/08/2007US20070031879 Novel enterokinase cleavage sequences
02/08/2007US20070031878 Methods and compositions for polypeptide engineering
02/08/2007US20070031860 G-protein coupled receptor and uses therefor
02/08/2007US20070031855 Receptor for a bacillus thuringiensis toxin
02/08/2007US20070031837 Genetic markers for skatole metabolism
02/08/2007US20070031836 Altered Bacillus SecA comprising at least one amino acid change in IRA-1 and/or IRA-2 (intramolecular regulator of ATP hydrolysis)
02/08/2007US20070031506 Interleukin-18 inducer
02/08/2007US20070031478 Modified peptides and their uses
02/08/2007US20070031452 rheumatoid arthritis; nervous system disorders; endogenous retroviral elements (ERV)
02/08/2007US20070031445 Compositions and methods for enhancing immune responses mediated by antigen-presenting cells
02/08/2007US20070031444 Compounds targeted to cellular locations
02/08/2007US20070031442 Method and compositions for boosting immune response
02/08/2007US20070031440 Modified transferin-antibody fusion proteins
02/08/2007US20070031439 Novel protein related to melanoma-inhibiting protein and uses thereof
02/08/2007US20070031438 Antibodies as chimeric effector cell receptors against tumor antigens
02/08/2007US20070031436 Bivalent monomeric Fv antibody formed by one single-chain Fv monomer having four variable domains; expression plasmids which code for an Fv antibody; diagnosis; stability; no undesired immune response; side effect reduction; lack constant domains
02/08/2007US20070031435 Polypeptide compounds for inhibiting angiogenesis and tumor growth
02/08/2007US20070031433 Tumor antigen
02/08/2007US20070031432 Tumor antigen
02/08/2007US20070031431 polypeptides consisting of amino acid sequences or peptide fragments and drug carriers, used for inducing and/or activating human leukocyte antigens (HLA-A2)-restricted tumor-specific cytotoxic T lymphocytes; anticancer vaccines
02/08/2007US20070031422 Selection of cells expressing heteromeric polypeptides
02/08/2007US20070031421 Inhibitors targeting osteoclast-associated protein
02/08/2007US20070031414 DR5 antibodies and uses thereof
02/08/2007US20070031410 POP2: NFkB - Inhibiting Polypeptides, Nucleic Acids and Methods of Use
02/08/2007US20070031409 Recombinant DNA-molecule complex for the expression of anti-human-interferon-gamma chimeric antibodies or antibody fragments
02/08/2007US20070031407 Peptide or protein containing a C'-D loop of the CD28 receptor family
02/08/2007US20070031405 Use of A33 antigens and jam-it
02/08/2007US20070031401 Metalloprotease catalytic site for use in identifying modulators for prevention and treatment of respiratory system disorders
02/08/2007US20070031399 Use of proline specific endoproteases to hydrolyse peptides and proteins
02/08/2007US20070031395 Repressor of skeletal muscle differentiation, nucleic acid coding therefor and the use thereof in diagnosis and therapy
02/08/2007US20070031376 In which IL-6R and IL-6 are directly linked without a linker; blood platelet proliferating agent, ex vivo amplifier for hematopoietic stem cells
02/08/2007CA2620937A1 Cancerous disease modifying antibodies
02/08/2007CA2617832A1 Yeast host, transformant and method for producing heterologous proteins
02/08/2007CA2617458A1 Cancerous disease modifying antibodies
02/08/2007CA2617454A1 Cancerous disease modifying antibodies
02/08/2007CA2617447A1 Cancerous disease modifying antibodies
02/08/2007CA2617446A1 Cancerous disease modifying antibodies
02/08/2007CA2617138A1 Mutant timp-3
02/07/2007EP1749886A2 Polypeptides having kinase activity, their preparation and use
02/07/2007EP1749836A2 Recombinant vascular endothelial cell growth factor D (VEGF-D)
02/07/2007EP1749538A1 Methods of inducing differentiation of regulatory t-cells and proliferating the same with gpi anchor protein agonist and medicinal composition therefor
02/07/2007EP1749102A2 Transgenic animals and uses thereof
02/07/2007EP1749025A2 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of colon cancer
02/07/2007EP1749022A2 Methods for cyclizing synthetic polymers
02/07/2007EP1497634A4 Protein knobs
02/07/2007EP1272609B1 Single chain antibody against mutant p53
02/07/2007EP1218491B1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor
02/07/2007EP1092029B1 Human thrombopoietin mutein
02/07/2007EP0909272B1 Helicobacter pylori adhesin binding group antigen
02/07/2007EP0870022B1 Immunostimulatory composition and method
02/07/2007EP0504363B2 PURIFIED IgG ANTIBODIES
02/07/2007CN1910195A Uses of spatial configuration to modulate protein function
02/07/2007CN1909930A Transglutaminase mediated conjugation of peptides
02/07/2007CN1909922A Novel flavivirus antigens
02/07/2007CN1908183A Enzyme medium hybrid peptide of native protein with endothelin antagonism
02/07/2007CN1908170A Lim mineralization protein splice variants